Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Dang

Showing results (461-470 of 528) with videos related to

Pageof 53
Sort By:
Seminars in Oncology|February 28, 2001
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphomaP McLaughlin, F B Hagemeister, M A Rodriguez, et al.
Journal of Kidney Cancer and VHL|March 23, 2017
Displacement of the Spleen Mimicking Renal Cell Cancer Recurrence Post-Nephrectomy: A Case ReportCarolina S Emanuels, Krista D Timmerman, Tabish Aijaz, et al.
Oncology Letters|April 30, 2017
Stereotactic body radiation therapy for oligoprogression of metastatic disease from gastrointestinal cancers: A novel approach to extend chemotherapy efficacyJustin Wray, Rana Fawzi Hawamdeh, Nalini Hasija, et al.
JAMA Network Open|September 29, 2022
Primary Care Practitioner Perceptions on the Follow-up of Abnormal Cancer Screening Test ResultsSteven J Atlas, Anna N A Tosteson, Timothy E Burdick, et al.
Respiratory Care|January 30, 2020
Respiratory Volume Monitoring in the Perioperative Setting Across Multiple CentersChunyuan Qiu, Eugene Cheng, Shawn R Winnick, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2025
Process mapping to compare and improve management of abnormal cervical cancer screening results in two U.S. healthcare systems within the PROSPR ConsortiumRobin T Higashi, Lisa Quirk, Gina Kruse, et al.
Cell Death & Disease|May 22, 2021
IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cellsTakumi Itoh, Ryo Hatano, Yoshiya Horimoto, et al.
The Oncologist|January 29, 2021
Activity of Sorafenib Plus Capecitabine in Previously Treated Metastatic Colorectal CancerThomas J George, Alison M Ivey, Azka Ali, et al.
Cells|August 26, 2023
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell MalignanciesEiji Kobayashi, Yusuke Kamihara, Miho Arai, et al.
Studies in Health Technology and Informatics|June 8, 2022
Natural Language Processing to Identify Abnormal Breast, Lung, and Cervical Cancer Screening Test Results from Unstructured Reports to Support Timely Follow-upCourtney J Diamond, John Laurentiev, Jie Yang, et al.
Pageof 53

Showing results (461-470 of 528) with videos related to

Sort By:
Pageof 53
Seminars in Oncology|February 28, 2001
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphomaP McLaughlin, F B Hagemeister, M A Rodriguez, et al.
Journal of Kidney Cancer and VHL|March 23, 2017
Displacement of the Spleen Mimicking Renal Cell Cancer Recurrence Post-Nephrectomy: A Case ReportCarolina S Emanuels, Krista D Timmerman, Tabish Aijaz, et al.
Oncology Letters|April 30, 2017
Stereotactic body radiation therapy for oligoprogression of metastatic disease from gastrointestinal cancers: A novel approach to extend chemotherapy efficacyJustin Wray, Rana Fawzi Hawamdeh, Nalini Hasija, et al.
JAMA Network Open|September 29, 2022
Primary Care Practitioner Perceptions on the Follow-up of Abnormal Cancer Screening Test ResultsSteven J Atlas, Anna N A Tosteson, Timothy E Burdick, et al.
Respiratory Care|January 30, 2020
Respiratory Volume Monitoring in the Perioperative Setting Across Multiple CentersChunyuan Qiu, Eugene Cheng, Shawn R Winnick, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2025
Process mapping to compare and improve management of abnormal cervical cancer screening results in two U.S. healthcare systems within the PROSPR ConsortiumRobin T Higashi, Lisa Quirk, Gina Kruse, et al.
Cell Death & Disease|May 22, 2021
IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cellsTakumi Itoh, Ryo Hatano, Yoshiya Horimoto, et al.
The Oncologist|January 29, 2021
Activity of Sorafenib Plus Capecitabine in Previously Treated Metastatic Colorectal CancerThomas J George, Alison M Ivey, Azka Ali, et al.
Cells|August 26, 2023
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell MalignanciesEiji Kobayashi, Yusuke Kamihara, Miho Arai, et al.
Studies in Health Technology and Informatics|June 8, 2022
Natural Language Processing to Identify Abnormal Breast, Lung, and Cervical Cancer Screening Test Results from Unstructured Reports to Support Timely Follow-upCourtney J Diamond, John Laurentiev, Jie Yang, et al.
Pageof 53